Co-Investigator(Kenkyū-buntansha) |
YAMAMOTO Tetsuya 筑波大学, 医学医療系, 講師 (30375505)
KUMADA Hiroaki 筑波大学, 医学医療系, 准教授 (30354913)
NAKAI Kei 筑波大学, 医学医療系, 講師 (50436284)
ISOBE Tomonori 筑波大学, 医学医療系, 准教授 (70383643)
NARIAI Tadashi 東京医科歯科大学, 医学部附属病院, 講師 (00228090)
|
Budget Amount *help |
¥19,240,000 (Direct Cost: ¥14,800,000、Indirect Cost: ¥4,440,000)
Fiscal Year 2011: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2009: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2008: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
|
Research Abstract |
We started BNCT for newly diagnosed glioblastoma and recurrent malignant brain tumor with the new protocol. In Newly diagnosed glioblastoma case, progression free survival was 13 month, and overall survival was 21month.In recurrent malignant brain tumor case, we perform BNCT for 2 cases. Recurrent glioblastoma case revealed radiation necrosis and skin necrosis but tumor was stable during 2 years of follow up period. Malignant meningioma case is recurrence free during 2 years of follow up period.
|